

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
681 daily bars · split adjusted
Current price $53.02
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 13, 26 |
Daily · Wilder smoothing
| UBS |
| maintain |
| Buy |
| Buy |
| Oct 13, 26 | Barclays | maintain | Overweight | Overweight |
| Sep 2, 26 | Scotiabank | maintain | Sector Outperform | Sector Outperform |
| Aug 31, 26 | Barclays | maintain | Overweight | Overweight |
| Aug 19, 26 | Keybanc | maintain | Overweight | Overweight |
| Aug 14, 26 | RBC Capital | maintain | Outperform | Outperform |
| Aug 14, 26 | Truist Securities | maintain | Buy | Buy |
| Aug 13, 26 | Citigroup | maintain | Buy | Buy |
| Jul 27, 26 | Citizens | maintain | Market Outperform | Market Outperform |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 52.53 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 69.75 | Oscillator | Neutral |
| Williams %R (14) | -31.58 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.12 (Hist 0.31) | Oscillator | Strong Buy |
| Average Directional Index (14) | 20.55 (+DI 18.3 / -DI 14.2) | Trend | Buy |
| EMA 20 | 52.54 | MA | Buy |
| SMA 20 | 51.90 | MA | Buy |
| EMA 50 | 52.87 | MA | Buy |
| SMA 50 | 53.40 | MA | Sell |
| SMA 200 | 51.34 | MA | Strong Buy |
TTM vs. 5-year historical average (annual ratios)
| Metric | AHR | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 77.9x | -5.5x · sector 35.5x | Elevated |
| Forward P/E (FY26E) | 89.2x | EPS est. 0.59 | In line |
| Price / Book | 2.7x | 1.2x | Elevated |
| Price / Sales | 4.6x | 1.4x | Elevated |
| EV / EBITDA | 28.4x | 18.2x | Elevated |
| Return on equity | 3.7% | — | Weak |
| Gross margin | 14.9% | 19.0% | Below hist. |
| Debt / Equity | 0.42 | 1.46 | Conservative |
| Piotroski / Altman Z | 5/9 | Z 3.52 | Safe zone |
Discounted cash flow model
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 1, 26 | Chang Aric Ching-Pao | 0 | — | ||
| Sep 25, 26 | Foster Mark E. | officer: EVP, GC & Secretary | S-Sale | 1,500 @ $52.06 | $78.09K |
| Sep 1, 26 | Foster Mark E. | officer: EVP, GC & Secretary | S-Sale | 2,000 @ $55.39 | $110.8K |
| Jul 21, 26 | Prosky Danny | director | A-Award | 2,594 | — |
| Jul 21, 26 | Hanson Jeffrey T | director, officer: Chief Executive Officer | A-Award | 35,981 | — |
| Jul 21, 26 | Willhite Gabriel M | officer: President & COO | A-Award | 6,038 | — |
| Jul 21, 26 | Prosky Danny | director | M-Exempt | 20,912 | — |
| Jul 21, 26 | Prosky Danny | director | M-Exempt | 30,886 | — |
Stock news · updated daily
Here is how American Healthcare REIT (AHR) and HCI Group (HCI) have performed compared to their sector so far this year.
American Healthcare REIT (AHR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Here is how American Healthcare REIT (AHR) and Banco Bilbao (BBVA) have performed compared to their sector so far this year.
IRVINE, Calif.--(BUSINESS WIRE)-- #CA--American Healthcare REIT, Inc. (the “Company”) (NYSE: AHR) announced today that it will issue its third quarter 2026 earnings release on Thursday, November 5, 2026, after the close of trading.A public conference call with a simultaneous webcast will be held on Friday, November 6, 2026, at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time. During the conference call, company executives will review third quarter 2026 results, discuss recent events, and conduct a que.
American Healthcare REIT, Inc. (NYSE: AHR - Get Free Report) announced a quarterly dividend on Friday, September 18th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.25 per share on Friday, October 16th. This represents a $1.00 annualized dividend and a yield of 1.9%. The ex-dividend date is Wednesday, September 30th.
AHR, TRNO and RLJ stand out as modern assets, healthy demand and balance sheet flexibility offset persistent REIT industry headwinds.
IRVINE, Calif.--(BUSINESS WIRE)-- #AHR--American Healthcare REIT, Inc. (NYSE: AHR) announced today that its board of directors has declared a quarterly distribution of $0.25 per share for the quarter ending September 30, 2026. The distribution will be payable in cash on or about October 16, 2026, to all holders of record of its common stock as of the close of business on September 30, 2026.About American Healthcare REIT, Inc.American Healthcare REIT, Inc. (NYSE: AHR) is a real estate investment trust t.
Here is how American Healthcare REIT (AHR) and Banco Bilbao (BBVA) have performed compared to their sector so far this year.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | 0.14 | 0.16 | Beat 16.6% | $671.0M |
| May 7, 2026 | 0.16 | 0.13 | Miss -19.2% | $650.8M |
| Feb 26, 2026 | 0.15 | 0.06 | Miss -61.3% | $604.1M |
| Nov 6, 2025 | 0.42 | 0.33 | Miss -21.4% | $572.9M |
| Aug 7, 2025 | 0.40 | 0.06 | Miss -85.0% | $542.5M |
| May 8, 2025 | 0.37 | -0.04 | Miss -110.8% | $540.6M |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 3 | Oct 2, 2026 | 2026-10-02 16:15:08 | View |
| 4 | Sep 28, 2026 | 2026-09-28 16:22:19 | View |
| 8-K | Sep 18, 2026 | 2026-09-18 16:25:15 | View |
| 8-K | Sep 14, 2026 | 2026-09-14 06:35:15 | View |
| 8-K | Sep 2, 2026 | 2026-09-02 17:22:39 | View |
| 4 | Sep 1, 2026 | 2026-09-01 21:07:13 | View |
| 144 | Sep 1, 2026 | 2026-09-01 16:37:34 | View |
| 8-K | Sep 1, 2026 | 2026-09-01 16:29:34 | View |
| 8-K | Aug 24, 2026 | 2026-08-24 16:16:45 | View |
| 8-K | Aug 12, 2026 | 2026-08-12 16:16:31 | View |
Proxy statement (DEF 14A) disclosures